INVESTMENTS

Portfolio

WE’RE ALREADY DELIVERING
WITH OUR FIRST INVESTMENT (2019) IN COPENHAGEN BASED OCTARINE BIO

OUR FIRST INVESTMENT: OCTARINE BIO

  • Company Octarine
  • Investment Area Emerging Markets, Derived Products and Circular Economy
  • Location Copenhagen, Denmark
  • Website: https://octarinebio.com/
ABOUT

Octarine harnesses synthetic biology to develop functionally superior cannabinoid and psilocybin derivatives.
Our mission is to improve the health and well-being of people worldwide

Using our unique biosynthetic platform we engineer microorganisms to produce a range of natural and novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties.

 

OUR SECOND INVESTMENT: HERBOLEA

ABOUT

Herbolea develops and licenses proprietary, solvent-less technologies to transform botanicals into superior quality products.